Bioingenium

Bioingenium is a privately held, revenue-generating CDMO based in Madrid, Spain, with operational facilities in Barcelona Science Park. It provides end-to-end bioprocess development and protein manufacturing services using microbial and mammalian systems, positioning itself as a value-added partner for biologics developers. With over 15 years of expertise, a highly qualified team, and ISO 9001:2015 certification, the company focuses on quality, flexibility, and technical excellence to meet the growing demand for outsourced biomanufacturing. Its client base spans more than 20 countries, primarily serving pre-clinical and early-stage drug development programs.

Three recombinant protein expression systems: Bacterial (E. coli), Mammalian (CHO/HEK), and Yeast (Pichia pastoris). Full in-house support for cell line engineering, upstream, and downstream process development.

Bioingenium competes in the fragmented global biologics CDMO market, facing competition from large players like Lonza, Samsung Biologics, and Fujifilm Diosynth, as well as numerous mid-sized and niche specialists. Its differentiation lies in its deep scientific expertise, flexible partnership model, and recognized specialization in microbial and yeast expression systems.